Cargando…
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
The treatment of metastatic gastrointestinal stromal tumors (GISTs) changed dramatically with the introduction of imatinib into the therapeutic lexicon in 2001. Over the past 15 years, tyrosine kinase inhibitors in the adjuvant and metastatic settings have remained the standard of care for this dise...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315077/ https://www.ncbi.nlm.nih.gov/pubmed/28261637 http://dx.doi.org/10.1007/s40487-015-0014-7 |